Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases

Annalisa Siri, Vera Knäuper, Natalia Veirana, Fabio Caocci, Gillian Murphy, Luciano Zardi

Journal of Biological Chemistry · 1995 · 164 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Two major tenascin-C (TN-C) isoforms are generated by the alternative splicing of the pre-mRNA. The large isoform contains seven extra type three repeats that, by contrast, are omitted in the small TN-C isoform. The large TN-C isoform is mainly expressed at the onset of cellular processes that entail active cell migration, proliferation, or tissue remodeling such as occur in neoplasia, wound healing, and during development. Thus, the large TN-C isoform seems to be a specific component of the provisional extracellular matrix. Here we have studied the degradation of the large and small TN-C isoforms by matrix metalloproteinases (MMPs) 2, 3, 7, and 9. Among these proteolytic enzymes only MMP-7 can degrade the small TN-C isoform removing the NH2-terminal knob. The large TN-C isoform shows the same MMP-7-sensitive site adjacent to the NH2-terminal sequence, but is further degraded in the splicing area where three fibronectin-like type III repeats are completely digested. Moreover, the large TN-C isoform is degraded by MMP-2 and MMP-3 which completely digest a single type III repeat inside the splicing area. By contrast, the large TN-C isoform is resistant to MMP-9 digestion. The results show that the presence of the spliced sequence introduces new protease-sensitive sites in the large TN-C isoform. Two major tenascin-C (TN-C) isoforms are generated by the alternative splicing of the pre-mRNA. The large isoform contains seven extra type three repeats that, by contrast, are omitted in the small TN-C isoform. The large TN-C isoform is mainly expressed at the onset of cellular processes that entail active cell migration, proliferation, or tissue remodeling such as occur in neoplasia, wound healing, and during development. Thus, the large TN-C isoform seems to be a specific component of the provisional extracellular matrix. Here we have studied the degradation of the large and small TN-C isoforms by matrix metalloproteinases (MMPs) 2, 3, 7, and 9. Among these proteolytic enzymes only MMP-7 can degrade the small TN-C isoform removing the NH2-terminal knob. The large TN-C isoform shows the same MMP-7-sensitive site adjacent to the NH2-terminal sequence, but is further degraded in the splicing area where three fibronectin-like type III repeats are completely digested. Moreover, the large TN-C isoform is degraded by MMP-2 and MMP-3 which completely digest a single type III repeat inside the splicing area. By contrast, the large TN-C isoform is resistant to MMP-9 digestion. The results show that the presence of the spliced sequence introduces new protease-sensitive sites in the large TN-C isoform. Human tenascin-C (TN-C) 1The abbreviations used are:TN-Ctenascin-CFNfibronectinMMPmatrix metalloproteinasePAGEpolyacrylamide gel electrophoresisEGFepidermal growth factorECMextracellular matrixmAbmonoclonal antibodyBHKbaby hamster kidney. 1The abbreviations used are:TN-Ctenascin-CFNfibronectinMMPmatrix metalloproteinasePAGEpolyacrylamide gel electrophoresisEGFepidermal growth factorECMextracellular matrixmAbmonoclonal antibodyBHKbaby hamster kidney. is an extracellular matrix glycoprotein composed of six similar subunits joined at their NH2-terminal by disulfide bonds (1Erickson H.P. Bourdon M.A. Annu. Rev. Cell Biol. 1989; 5: 71-92Crossref PubMed Scopus (526) Google Scholar, 2Ekblom P. Aufderheide E. Int. J. Dev. Biol. 1989; 33: 71-79PubMed Google Scholar, 3Edelman G.M. Jones F.S. Trends Biochem. Sci. 1992; 17: 228-232Abstract Full Text PDF PubMed Scopus (47) Google Scholar, 4Chiquet-Ehrismann R. Semin. Cancer Biol. 1993; 4: 301-310PubMed Google Scholar, 5Erickson H.P. Curr. Opin. Cell Biol. 1993; 5: 869-876Crossref PubMed Scopus (355) Google Scholar, 6Crossin K.L. Perspect. Dev. Neurobiol. 1994; 2: 21-32PubMed Google Scholar, 7Tucker R.P. The Function of Tenascin: Hypotheses and Current Knowledge, Perspectives on Developmental Neurobiology. Vol. 2. Gordon and Breach, Yverdon, Switzerland1994Google Scholar). During development, TN-C displays a time and space-dependent tissue distribution with morphogenetically significant boundaries. Each human TN-C subunit includes three types of structural modules: 14½ epidermal growth factor-like repeats, 15 fibronectin (FN) type three homology repeats, and a COOH-terminal knob made up of a sequence with homology to the globular domain of the β and γ chains of human fibrinogen (see Fig. 3). TN-C is coded for by a single gene and its expression is regulated by a single promoter (8Jones F.S. Crossin K.L. Cunningham B.A. Edelman G.M. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 6497-6501Crossref PubMed Scopus (49) Google Scholar, 9Gherzi R. Carnemolla B. Siri A. Ponassi M. Balza E. Zardi L. J. Biol. Chem. 1995; 270: 3429-3434Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar). Structurally and functionally different human TN-C isoforms are generated by alternative splicing of the TN-C transcript, seven type three repeats being included or omitted in the mRNA (see Fig. 3) (10Gulcher J.R. Nies D.E. Marton L.S. Stefansson K. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 1588-1592Crossref PubMed Scopus (122) Google Scholar, 11Siri A. Carnemolla B. Saginati M. Leprini A. Casari G. Baralle F. Zardi L. Nucleic Acids Res. 1991; 19: 525-531Crossref PubMed Scopus (161) Google Scholar) generating two major TN-C isoforms with molecular masses of about 300 and 200 kDa, respectively. Analysis of TN-C isoform ratio has shown that, in human malignantly transformed cultured cells as well as in breast carcinoma and in some cases of lung carcinoma, the higher molecular mass isoform is preferentially expressed (12Carnemolla B. Borsi L. Bannikov G. Troyanovsky S. Zardi L. Eur. J. Biochem. 1992; 205: 561-567Crossref PubMed Scopus (31) Google Scholar, 13Borsi L. Carnemolla B. Nicol G. Spina B. Tanara G. Zardi L. Int. J. Cancer. 1992; 52: 688-692Crossref PubMed Scopus (158) Google Scholar, 14Oyama F. Hirohashi S. Shimosato Y. Titani K. Sekiguchi K. Cancer Res. 1991; 51: 4876-4881PubMed Google Scholar, 15Ventimiglia J.B. Wikstrand C.J. Ostrowski L.E. Bourdon M.A. Lightner V.A. Bigner D.D. J. Neuroimmunol. 1992; 36: 41-55Abstract Full Text PDF PubMed Scopus (77) Google Scholar, 16Leprini A. Querzé G. Zardi L. Perspect. Dev. Neurobiol. 1994; 2: 117-123PubMed Google Scholar, 17Sakakura T. Kusakabe M. Perspect. Dev. Neurobiol. 1994; 2: 111-116PubMed Google Scholar). More recently it has been shown that mitogenic stimulation of cultured fibroblasts induces a modification of the ratio between the two TN-C isoforms, the expression of the larger isoform being increased to a much higher extent (18Borsi L. Balza E. Castellani P. Carnemolla B. Ponassi M. Querzé G. Zardi L. Cell Adhes. Commun. 1994; 1: 307-317Crossref PubMed Scopus (37) Google Scholar). Differences in biological functions and sites of expression between TN-C isoforms have been reported (19Saga Y. Sukamoto T. Jing N. Kusakabe M. Sakakura T. Gene (Amst.). 1991; 104: 177-185Crossref PubMed Scopus (90) Google Scholar, 20Chuong C.-M. Chen H.-M. Am. J. Pathol. 1991; 138: 427-440PubMed Google Scholar, 21Tucker R.P. Hammarback J.A. Jenrath D.A. Mackie E.J. Xu Y. J. Cell Sci. 1993; 104: 69-76Crossref PubMed Google Scholar, 22Julian J.A. Chiquet-Ehrismann R. Erickson H.P. Carson D.D. Development. 1994; 120: 661-671Crossref PubMed Google Scholar, 23Prieto A.L. Jones F.S. Cunningham B.A. Crossin K.L. Edelman G.M. J. Cell Biol. 1990; 111: 685-698Crossref PubMed Scopus (139) Google Scholar, 24Weller A. Beck S. Ekblom P. J. Cell Biol. 1991; 112: 355-362Crossref PubMed Scopus (148) Google Scholar, 25Tucker R.P. Brunso-Bechtold J.K. Jenrath D.A. Khan N.A. Poss P.M. Sweatt A.J. Xu Y. Perspect. Dev. Neurobiol. 1994; 2: 89-100PubMed Google Scholar). Murphy-Ullrich et al. (26Murphy-Ullrich J.E. Lightner V.A. Aukhil I. Yan Y.Z. Erickson H.P. Hook M. J. Cell Biol. 1991; 115: 1127-1136Crossref PubMed Scopus (243) Google Scholar) have demonstrated that focal adhesion integrity is down-regulated by the alternative spliced domain of human TN-C. Chiquet-Ehrismann et al. (27Chiquet-Ehrismann R. Matsuoka Y. Hofer U. Spring J. Bernasconi C. Chiquet M. Cell Regul. 1991; 2: 927-938Crossref PubMed Scopus (136) Google Scholar) have shown that the chicken TN-C isoform lacking the alternatively spliced domain binds more strongly to FN than the isoform in which this domain is included, and Kaplony et al. (28Kaplony A. Zimmermann D.R. Fischer R.W. Imhof B.A. Odermatt B.F. Winterhalter K.H. Vaughan L. Development. 1991; 112: 605-614Crossref PubMed Google Scholar) reported that expression of high molecular mass TN-C correlates with corneal cell migration. Moreover, recent reports have shown that the two TN-C isoforms bind to the cell surface through different receptors; in fact, the large TN-C isoform strongly interacts with annexin II in glioma and endothelial cells (29Chung C.Y. Erickson H.P. J. Cell Biol. 1994; 126: 539-548Crossref PubMed Scopus (205) Google Scholar) while the neuronal cell adhesion molecule contactin/F11 mainly binds the small TN-C isoform (30Zisch A.H. D'Alessandri L. Ranscht B. Falchetto R. Winterhalter K.H. Vaughan L. J. Cell Biol. 1992; 119: 203-213Crossref PubMed Scopus (153) Google Scholar, 31Vaughan L. Weber P. D'Alessandri L. Zisch A.H. Winterhalter K.H. Perspect. Dev. Neurobiol. 1994; 2: 43-52PubMed Google Scholar). tenascin-C fibronectin matrix metalloproteinase polyacrylamide gel electrophoresis epidermal growth factor extracellular matrix monoclonal antibody baby hamster kidney. tenascin-C fibronectin matrix metalloproteinase polyacrylamide gel electrophoresis epidermal growth factor extracellular matrix monoclonal antibody baby hamster kidney. Since extracellular matrix degradation is a crucial step in tumor invasion, a differential susceptibility of the different TN-C isoforms to the proteolytic enzymes released by neoplastic cells may take part in this mechanism. In particular, matrix metalloproteinases (MMPs) are known to be produced by several tumor tissues and are involved in proteolytic degradation of tumor extracellular matrix. In fact, it has been reported that various murine and human tumor-derived cell lines transcribe, synthesize and secrete MMP enzymes (32McDonnell S. Matrisian L.M. Cancer Metastasis Rev. 1990; 9: 305-319Crossref PubMed Scopus (106) Google Scholar, 33Stetler-Stevenson W.G. Aznavoorian S. Liotta L.A. Annu. Rev. Cell Biol. 1993; 9: 541-573Crossref PubMed Scopus (1521) Google Scholar). These enzymes are also synthesized and secreted by normal cells under conditions that may be associated with physiologic tissue remodeling. Here, we have compared the susceptibility of small and large TN-C isoforms to degradation by MMP-2, MMP-3, MMP-7, and MMP-9. Results show that the large TN-C isoform is much more sensitive to MMP proteolytic activity. Baby hamster kidney (BHK) cells transfected with TN-C cDNA constructs (11Siri A. Carnemolla B. Saginati M. Leprini A. Casari G. Baralle F. Zardi L. Nucleic Acids Res. 1991; 19: 525-531Crossref PubMed Scopus (161) Google Scholar) in the pNUT expression vector were a gift of Dr H. P. Erickson (34Aukhil I. Joshi P. Yan Y. Erickson H.P. J. Biol. Chem. 1993; 268: 2542-2553Abstract Full Text PDF PubMed Google Scholar). Two clones, HxB.L and HxB.S produce the large and the small TN-C splice variants, respectively (large TN-C and small TN-C). Cells were grown in Dulbecco's modified Eagle's medium (HyClone Europe Ltd. Cramlington, UK) containing 10% fetal calf serum obtained from Boehringer (Mannheim, Germany). Preparation and characterization of seven mAbs used has already been reported (35Balza E. Siri A. Ponassi M. Caocci F. Linnala A. Virtanen I. Zardi L. FEBS Lett. 1993; 332: 39-43Crossref PubMed Scopus (72) Google Scholar). Three new mAbs, BC-8, BC-9, and BC-10, not previously described, have been characterized in this study using the procedure previously described (35Balza E. Siri A. Ponassi M. Caocci F. Linnala A. Virtanen I. Zardi L. FEBS Lett. 1993; 332: 39-43Crossref PubMed Scopus (72) Google Scholar) based on analysis of mAb reaction in immunoblotting with different TN-C-β-galactosidase fusion proteins. Recombinant MMP-2, MMP-3, MMP-7, and MMP-9 were purified from conditioned culture medium of transfected NSO mouse myeloma cells essentially as previously described (36Koklitis P.A. Murphy G. Sutton C. Angal S. Biochem. J. 1991; 276: 217-221Crossref PubMed Scopus (67) Google Scholar, 37Crabbe T. Willenbrock F. Eaton D. Hynds P. Carne A.F. Murphy G. Docherty A.J.P. Biochemistry. 1992; 31: 8500-8507Crossref PubMed Scopus (93) Google Scholar, 38Murphy G. Willenbrock F. Ward R.V. Cockett M.I. Eaton D. Docherty A.J.P. Biochem. J. 1992; 283: 637-641Crossref PubMed Scopus (246) Google Scholar). The purified proenzymes were activated by treatment with 1 m M aminophenyl-mercuric acetate for 1 h at 25°C (MMP-2) or 37°C (MMP-3, −7, and −9). Small and large TN-C splicing variants were purified from conditioned culture medium of BHK-transfected cell lines using an immunoadsorbent prepared with the mAb BC-4 as already reported (12Carnemolla B. Borsi L. Bannikov G. Troyanovsky S. Zardi L. Eur. J. Biochem. 1992; 205: 561-567Crossref PubMed Scopus (31) Google Scholar). Each isoform was more than 95% pure as judged by SDS-polyacrylamide gel electrophoresis (PAGE) and the amount of TN-C was evaluated using the absorption coefficient A277(1 mg/ml, 1 cm) of 0.97 (1Erickson H.P. Bourdon M.A. Annu. Rev. Cell Biol. 1989; 5: 71-92Crossref PubMed Scopus (526) Google Scholar). 300 μg of the two TN-C isoforms were incubated with either 5 μg of active MMP-7, 13 μg of active MMP-2, or 15 μg of active MMP-3 or MMP-9 in 100 m M Tris/HCl, pH 7.5, 100 m M NaCl, 5 m M CaCl2for 24 h at 37°C. The digestion products were analyzed by SDS-PAGE under reducing conditions followed by Coomassie Blue staining or immunoblotting carried out as previously reported (39Carnemolla B. Balza E. Siri A. Zardi L. Nicotra M.R. Bigotti A. Natali P.G. J. Cell Biol. 1989; 108: 1139-1148Crossref PubMed Scopus (297) Google Scholar). Amino-terminal sequencing of the fragments was performed by TIB MolBiol (Genoa, Italy). Fragments to be analyzed were run on SDS-PAGE under reducing conditions and blotted on an Immobilon-P membrane (Millipore, Bedford, MA). The bands were revealed by staining with Ponceau S (Gelman Sciences, Ann Arbor, MI) and isolated by cutting the membrane. MMP-2, MMP-3, MMP-7, and MMP-9 were used to digest the large TN-C isoform under the conditions described under “Materials and Methods.” The products obtained were analyzed by SDS-PAGE under reducing conditions and are shown in Fig. 1 A. The digests were also analyzed by immunoblotting using 10 mAbs specific for different epitopes of TN-C (see Fig. 3) and the NH2-terminal sequences of the major fragments were determined. Three different patterns were observed. MMP-7 degraded 100% of large TN-C molecules and three major fragments with molecular masses of 170, 65, and 16 kDa, were generated (fragments L-170, L-65, and L-16) (Fig. 1). Analysis of these bands by immunoblotting with specific mAbs is shown in Fig. 2 and Table I. According to molecular mass and reaction with the different mAbs, the L-170 band was identified as a fragment including the EGF-like repeats and the FN like repeats 1 to A2. From the molecular mass and mAb reactivity we deduced that the L-65 fragment contains the fibrinogen-like COOH-terminal knob plus the FN like repeats 6 to 8. The mAb BC-7, specific for an epitope located in the amino-terminal portion of the molecule, reacted with the L-16 band. Since no other band with a higher molecular mass was stained by this mAb, the results show that the cleavage of the amino-terminal sequence occurred in 100% of the large TN-C molecules.Table I:Reactivity of TN-C fragments with different monoclonal antibodiesTable I:Reactivity of TN-C fragments with different monoclonal antibodiesDigests obtained with MMP-7 and MMP-2 were analyzed in immunoblotting with 10 different TN-C-specific mAbs. Positive (+) or negative. (-) reaction of each resistant fragment identified in Fig. 1, A and B, is reported. The localization within the TN-C molecule of the epitopes recognized by the various mAbs is reported in Fig. 3. The numbers of NH2-terminal residue of major fragments are reported. obtained with MMP-7 and MMP-2 were analyzed in immunoblotting with 10 different TN-C-specific mAbs. Positive (+) or negative. (-) reaction of each resistant fragment identified in Fig. 1, A and B, is reported. The localization within the TN-C molecule of the epitopes recognized by the various mAbs is reported in Fig. 3. The numbers of NH2-terminal residue of major fragments are reported. Three mAbs with epitopes located in the splicing were with fragment L-170 and with fragment L-65 that the MMP-7 completely degraded the repeats to included in the splicing area under these The of the fragment generated by MMP-7 is in Fig. 3. Amino-terminal sequences of the fragments L-170 and L-65 this degradation (Fig. 3). MMP-2 and MMP-3 about of the large TN-C isoform two major fragments of about and (fragments and respectively. The of the large TN-C by MMP-2 was analyzed on a SDS-PAGE using the conditions described under “Materials and and is shown in Fig. 1 A. Analysis of these fragments with specific mAbs has demonstrated that the includes the amino-terminal of the molecule, the EGF-like and the repeats 1 to A2. The fragment includes the repeats to and 6 to as shown by mAb reaction to the molecular the fibrinogen like COOH-terminal The of reaction of mAb with either or fragments that its epitope in the repeat is completely by these The of the fragment generated by MMP-2 is in Fig. 3. Amino-terminal sequences of the fragment the of degradation (Fig. 3). MMP-9 not show degradation of the large TN-C isoform not of the results of large fragment analysis by immunoblotting are in Table and in Fig. 3, which also shows the localization within the TN-C molecules of the epitopes recognized by the various mAbs and the amino-terminal sequences of the Small TN-C of the small TN-C isoform was carried out using the same enzymes and under the same conditions as for large TN-C. The results have shown that small TN-C is much more resistant than the large isoform. MMP-2, MMP-3 and large and MMP-9 not small TN-C. MMP-7 100% of the two fragments in SDS-PAGE (Fig. 1 has an molecular mass of and the of about 16 and respectively. Analysis with specific mAbs that the is the NH2-terminal while the fragment includes the part of the molecule from the of the EGF-like repeats to the fibrinogen like COOH-terminal The of the fragment generated by MMP-7 is in Fig. Amino-terminal sequence of the fragment this of degradation (Fig. The results are in Table I. of the extracellular matrix is a crucial step of tumor and W.G. Aznavoorian S. Liotta L.A. Annu. Rev. Cell Biol. 1993; 9: 541-573Crossref PubMed Scopus (1521) Google Scholar). can are to be the of matrix degradation W.G. Aznavoorian S. Liotta L.A. Annu. Rev. Cell Biol. 1993; 9: 541-573Crossref PubMed Scopus (1521) Google Scholar, L.M. 1992; PubMed Scopus Google Scholar, J. 1991; 5: PubMed Scopus Google Scholar). The human MMP of at which are active at pH and not of the More it has been demonstrated that a of TN-C and FN in the of and gene expression by fibroblasts P. Chiquet-Ehrismann R. Biol. 1994; 5: PubMed Scopus Google this being on an epitope in the fibronectin-like type III Thus, of the of the by TN-C presence the expression of involved in cell migration, tissue remodeling and in of tissues TN-C expression has been in a of tumor tissues (1Erickson H.P. Bourdon M.A. Annu. Rev. Cell Biol. 1989; 5: 71-92Crossref PubMed Scopus (526) Google Scholar, 17Sakakura T. Kusakabe M. Perspect. Dev. Neurobiol. 1994; 2: 111-116PubMed Google Scholar, A. J.E. Virtanen I. Pathol. 1991; PubMed Scopus Google Scholar, P.G. Zardi L. Int. J. Cancer. 1989; 4: Scopus (31) Google Scholar). Moreover, much has shown an increased expression of the TN-C isoform with a higher molecular mass with the onset of neoplastic in and in (12Carnemolla B. Borsi L. Bannikov G. Troyanovsky S. Zardi L. Eur. J. Biochem. 1992; 205: 561-567Crossref PubMed Scopus (31) Google Scholar, 13Borsi L. Carnemolla B. Nicol G. Spina B. Tanara G. Zardi L. Int. J. Cancer. 1992; 52: 688-692Crossref PubMed Scopus (158) Google Scholar, 14Oyama F. Hirohashi S. Shimosato Y. Titani K. Sekiguchi K. Cancer Res. 1991; 51: 4876-4881PubMed Google Scholar, 15Ventimiglia J.B. Wikstrand C.J. Ostrowski L.E. Bourdon M.A. Lightner V.A. Bigner D.D. J. Neuroimmunol. 1992; 36: 41-55Abstract Full Text PDF PubMed Scopus (77) Google Scholar). we have recently shown that cells produce only the large TN-C while cells mainly produce the small isoform (18Borsi L. Balza E. Castellani P. Carnemolla B. Ponassi M. Querzé G. Zardi L. Cell Adhes. Commun. 1994; 1: 307-317Crossref PubMed Scopus (37) Google Scholar). Analysis of TN-C to proteolytic degradation may about the involved in is about this et al. D.R. S. Edelman G.M. J. Cell Biol. PubMed Scopus Google Scholar) TN-C with and the resistant fragments by gel et al. Lightner V.A. D. G. Erickson H.P. J. Biochem. 1989; PubMed Scopus Google Scholar) described TN-C digestion by and the of cleavage sites in the TN-C were not in these More Chiquet et al. M. N. S. Beck K. Chiquet-Ehrismann R. Eur. J. Biochem. 1991; PubMed Scopus (47) Google Scholar) analyzed resistant fragments obtained by digestion with and of chicken TN-C in small or large splicing These have the resistant fragment in the TN-C molecule using specific mAbs and have shown that the large isoform is inside the spliced have studied the degradation patterns of small and large human TN-C isoforms obtained with different a of enzymes which are known to be more expressed in neoplastic and remodeling tissues than in the normal tissues W.G. Aznavoorian S. Liotta L.A. Annu. Rev. Cell Biol. 1993; 9: 541-573Crossref PubMed Scopus (1521) Google Scholar). have been to the cleavage sites through the analysis of resistant fragments with mAbs epitope localization within the TN-C molecule was already Results were by of the NH2-terminal sequences of the major fragments and have shown that the presence of the spliced sequence TN-C to these In fact, while large TN-C can be by MMP-7, and inside this sequence, small TN-C contains only a sensitive site to the NH2-terminal knob that is by by of TN-C purified from human cells has recently been reported by et al. K. Kusakabe M. Sakakura T. I. Y. FEBS Lett. 1994; PubMed Scopus Google Scholar). that TN-C produced by cells the large is sensitive to and degradation while it is resistant to MMP-2 and MMP-9. The on MMP-2 digestion not with degradation by this is only in as these about the localization within the TN-C molecule of the cleavage sites the of the two major TN-C isoforms to these The of the large TN-C isoform to MMP with the higher expression of this isoform in neoplastic and remodeling tissues R.P. Brunso-Bechtold J.K. Jenrath D.A. Khan N.A. Poss P.M. Sweatt A.J. Xu Y. Perspect. Dev. Neurobiol. 1994; 2: 89-100PubMed Google Scholar, E.J. Perspect. Dev. Neurobiol. 1994; 2: Google may the that the large TN-C isoform is a specific component of the provisional extracellular matrix and may to the of a more for cellular and migration. degradation by of TN-C its biological In fact, proteolytic cleavage may a to either or specific TN-C for and for are to L. for and

References

38